Clinical Trial: CAR-NK Cells (CL-NK-003) in Pancreatic Cancer

U.S., Feb. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07425483) titled 'CAR-NK Cells (CL-NK-003) in Pancreatic Cancer' on Feb. 12.

Brief Summary: This is a single-center, open-label, first-in-human, fixed-dose study in patients with pancreatic cancer.

Study Start Date: Feb. 12

Study Type: INTERVENTIONAL

Condition: Pancreatic Cancer

Intervention: BIOLOGICAL: CL-NK-003

Fixed-dose (3 x 10^9 cells)

Recruitment Status: RECRUITING

Sponsor: Changhai Hospital

Information provided by (Responsible Party): Zhuan Liao, Changhai Hospital

Published by HT Digital Content Services with permission from Health Daily Digest....